They resolved within the first few weeks at each new dose level
Clinical studies have documented reductions in total and free testosterone levels, increases in SHBG, and improvements in menstrual regularity following treatment with liraglutide or semaglutide
Additives and ingredients: Some patients find that certain nonnutritive sweeteners, sugar alcohols (sorbitol, maltitol), or other additives may trigger gastrointestinal distress
Recent clinical trials show that GLP-1/GIP dual agonists can significantly improve body weight, fasting and after-meal blood glucose levels, insulin sensitivity, and total cholesterol
When GLP-1 signaling improves, patients often report fewer headache days per month and reduced intensity of pain episodes